Long‐term titrated recombinant interferon‐α2a in chronic hepatitis C: a randomized controlled trial
Maria Grazia Rumi(University of Milan), Massimo Colombo(University of Milan), Friederike Zahm(Roche (Switzerland)), R. Romeo(Ospedale Maggiore), E. Del Ninno(University of Milan), R. Soffredini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), M. F. Donate(University of Milan), M. L. Parravicini(University of Milan)
Cited by 21
Related Papers
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
The natural history of compensated cirrhosis due to hepatitis C virus
|Hepatology|2006|631
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆
|Gastroenterology|2004|607